Is Asensus Surgical Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSEMKT: ASXC) stock is to Strong Buy ASXC stock.
Out of 2 analysts, 1 (50%) are recommending ASXC as a Strong Buy, 1 (50%) are recommending ASXC as a Buy, 0 (0%) are recommending ASXC as a Hold, 0 (0%) are recommending ASXC as a Sell, and 0 (0%) are recommending ASXC as a Strong Sell.
What is ASXC's forecast return on equity (ROE) for 2023-2026?
(NYSEMKT: ASXC) forecast ROE is N/A, which is considered weak.
What is ASXC's Price Target?
According to 2 Wall Street analysts that have issued a 1 year ASXC price target, the average ASXC price target is $1.50, with the highest ASXC stock price forecast at $2.00 and the lowest ASXC stock price forecast at $1.00.
On average, Wall Street analysts predict that Asensus Surgical's share price could reach $1.50 by Aug 22, 2024. The average Asensus Surgical stock price prediction forecasts a potential upside of 485.94% from the current ASXC share price of $0.26.
What is ASXC's forecast return on assets (ROA) for 2023-2026?
(NYSEMKT: ASXC) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 0%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.